The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
OREF Clinical Research Grant in Cellular Therapy
OREF, in partnership with the National Stem Cell Foundation, is pleased to announce it is now soliciting Letters of Intent (LOI) for the OREF Clinical Research Grant in Cellular Therapy in honor of James Urbaniak, MD, in Collaboration with the National Stem Cell Foundation (NSCF). The grant will provide up to $800,000 over a three-year period and is the largest grant ever offered by OREF.
This Funding Opportunity Announcement solicits investigator-initiated clinical research proposals focusing on adult stem cells (e.g., mesenchymal or adipose-derived). This grant program has been made possible through a partnership with the NSCF as well as other donors. Investigators who have demonstrated a sustained interest in research and excellence in their training are encouraged to apply.
Deadline for Letter of Intent: May 2, 2017
Applications may be submitted by domestic or Canadian non-profit, public and private institutions of higher education, such as hospitals, medical schools, universities, and colleges. If the PrinciaI Investigator (PI) is an orthopaedic surgeon, he/she must hold a primary appointment in an orthopaedic surgery department, work in an institution in the U.S. or Canada, and be licensed to practice in the United States.
If the PI is a PhD or DVM, he/she must hold a primary or secondary appointment at an institution/orthopaedic department in the U.S. or Canada. A letter from the department chair confirming the appointment is also required.